Paeds SAQs · fetal-neonatal-and-perinatal
Bronchopulmonary dysplasia and chronic neonatal lung disease
Short-answer questions on BPD prevention, classification, and management.
On this page & tools
Target exams
Question 1 (10 marks)
a) Classify this infant's BPD severity according to the NIH consensus definition. Justify your answer. (3 marks) This infant has severe BPD. The NIH consensus definition classifies severity at 36 weeks postmenstrual age. Severe BPD requires 30 percent or more supplemental oxygen and/or positive pressure ventilation at 36 weeks PMA. This infant is on 32 percent oxygen via nasal cannula, meeting the threshold for severe BPD [1].
b) List four evidence-based interventions that reduce the incidence of BPD in extremely preterm infants. (4 marks) Caffeine citrate (20 mg/kg loading, then 5 to 10 mg/kg daily) reduced BPD from 47 to 36 percent in the CAP trial [2]. Early CPAP strategy was non-inferior to prophylactic surfactant in the SUPPORT trial [3]. Vitamin A supplementation (5000 IU IM three times weekly for four weeks) reduces BPD with NNT of 14 to 20 [2]. Antenatal corticosteroids accelerate fetal lung maturation and reduce RDS severity [3].
c) What is the recommended oxygen saturation target range for preterm infants, and what evidence supports this? (3 marks) The recommended target is SpO₂ of 91 to 95 percent. The Cochrane review found lower targets (85 to 89 percent) increased mortality without reducing retinopathy, leading to adoption of the 91 to 95 percent range [1].
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References3Show ledgerHide ledger
- [1]Ehrenkranz RA, Walsh MC, Vohr BR, et al Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia Pediatrics, 2005.PMID 16322158
- [2]Schmidt B, Roberts RS, Davis P, et al Caffeine therapy for apnea of prematurity N Engl J Med, 2006.PMID 16707748
- [3]Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants N Engl J Med, 2010.PMID 20472939